591 related articles for article (PubMed ID: 24128992)
1. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
[TBL] [Abstract][Full Text] [Related]
2. Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of alpha-synuclein in HEK293 cells.
Sakamoto M; Arawaka S; Hara S; Sato H; Cui C; Machiya Y; Koyama S; Wada M; Kawanami T; Kurita K; Kato T
Biochem Biophys Res Commun; 2009 Jul; 384(3):378-82. PubMed ID: 19410557
[TBL] [Abstract][Full Text] [Related]
3. Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner.
Hara S; Arawaka S; Sato H; Machiya Y; Cui C; Sasaki A; Koyama S; Kato T
Mol Biol Cell; 2013 Jun; 24(11):1649-60, S1-3. PubMed ID: 23576548
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system.
Inglis KJ; Chereau D; Brigham EF; Chiou SS; Schöbel S; Frigon NL; Yu M; Caccavello RJ; Nelson S; Motter R; Wright S; Chian D; Santiago P; Soriano F; Ramos C; Powell K; Goldstein JM; Babcock M; Yednock T; Bard F; Basi GS; Sham H; Chilcote TJ; McConlogue L; Griswold-Prenner I; Anderson JP
J Biol Chem; 2009 Jan; 284(5):2598-2602. PubMed ID: 19004816
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production.
Kofoed RH; Zheng J; Ferreira N; Lykke-Andersen S; Salvi M; Betzer C; Reimer L; Jensen TH; Fog K; Jensen PH
Neurobiol Dis; 2017 Oct; 106():49-62. PubMed ID: 28648742
[TBL] [Abstract][Full Text] [Related]
6. Age- and brain region-dependent α-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains.
Chen M; Yang W; Li X; Li X; Wang P; Yue F; Yang H; Chan P; Yu S
Oncotarget; 2016 Feb; 7(8):8466-80. PubMed ID: 27032368
[TBL] [Abstract][Full Text] [Related]
7. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
Buck K; Landeck N; Ulusoy A; Majbour NK; El-Agnaf OM; Kirik D
Neurobiol Dis; 2015 Jun; 78():100-14. PubMed ID: 25818009
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation.
Dahmene M; Bérard M; Oueslati A
J Biol Chem; 2017 Mar; 292(9):3919-3928. PubMed ID: 28154193
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C
Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
Elfarrash S; Jensen NM; Ferreira N; Schmidt SI; Gregersen E; Vestergaard MV; Nabavi S; Meyer M; Jensen PH
PLoS One; 2021; 16(10):e0252635. PubMed ID: 34613964
[TBL] [Abstract][Full Text] [Related]
11. S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
Wu W; Sung CC; Yu P; Li J; Chung KKK
PLoS One; 2020; 15(4):e0232019. PubMed ID: 32343709
[TBL] [Abstract][Full Text] [Related]
12. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of polo like kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei.
Fitzgerald K; Bergeron M; Willits C; Bowers S; Aubele DL; Goldbach E; Tonn G; Ness D; Olaharski A
Toxicol Appl Pharmacol; 2013 May; 269(1):1-7. PubMed ID: 23466428
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of synucleins by members of the Polo-like kinase family.
Mbefo MK; Paleologou KE; Boucharaba A; Oueslati A; Schell H; Fournier M; Olschewski D; Yin G; Zweckstetter M; Masliah E; Kahle PJ; Hirling H; Lashuel HA
J Biol Chem; 2010 Jan; 285(4):2807-22. PubMed ID: 19889641
[TBL] [Abstract][Full Text] [Related]
15. Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants.
Salvi M; Trashi E; Marin O; Negro A; Sarno S; Pinna LA
Biochem Biophys Res Commun; 2012 Feb; 418(1):156-60. PubMed ID: 22248692
[TBL] [Abstract][Full Text] [Related]
16. Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce α-synuclein phosphorylation in rat brain.
Aubele DL; Hom RK; Adler M; Galemmo RA; Bowers S; Truong AP; Pan H; Beroza P; Neitz RJ; Yao N; Lin M; Tonn G; Zhang H; Bova MP; Ren Z; Tam D; Ruslim L; Baker J; Diep L; Fitzgerald K; Hoffman J; Motter R; Fauss D; Tanaka P; Dappen M; Jagodzinski J; Chan W; Konradi AW; Latimer L; Zhu YL; Sham HL; Anderson JP; Bergeron M; Artis DR
ChemMedChem; 2013 Aug; 8(8):1295-313. PubMed ID: 23794260
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.
Braithwaite SP; Stock JB; Mouradian MM
Rev Neurosci; 2012 Mar; 23(2):191-8. PubMed ID: 22499677
[TBL] [Abstract][Full Text] [Related]
18. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
Sato H; Kato T; Arawaka S
Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
[TBL] [Abstract][Full Text] [Related]
19. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
[No Abstract] [Full Text] [Related]
20. Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.
Wang R; Wang Y; Qu L; Chen B; Jiang H; Song N; Xie J
Neurochem Int; 2019 May; 125():127-135. PubMed ID: 30797969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
